Cardio Diagnostics Holdings Inc.

Cardio Diagnostics Holdings Inc.

NNASDAQ:CDIO
1.79
USD
-0.10
(-5.29%)
-2.45EPS
5.62MMarket Cap
Mar 03Next Earn

Total Valuation

USD

As of September 30, 2026, Cardio Diagnostics Holdings Inc. carries a market capitalization of 5.62M, placing it among publicly traded companies globally. Its enterprise value stands at 1.92M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap5.62M
Enterprise Value1.92M

Important Dates

Cardio Diagnostics Holdings Inc.'s next confirmed earnings release is scheduled for March 3, 2027.

Earnings Date3/3/2027

Share Statistics

As of September 30, 2026, Cardio Diagnostics Holdings Inc. has 2.96M shares outstanding.

Shares Outstanding2.96M

Valuation Ratios

These figures are as of September 30, 2026. The price-to-sales ratio is 331.13, and the price-to-book ratio stands at 0.98.

PS Ratio331.13
PB Ratio0.98
P/TBV Ratio1.20
P/FCF Ratio-0.83
P/OCF Ratio-0.87

Enterprise Valuation

These figures are as of September 30, 2026. The EV/Sales ratio of 126.37 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 1.92M versus a market cap of 5.62M, with the gap driven by net debt and cash on the balance sheet.

EV / Sales126.37

Financial Position

As of September 30, 2026, Cardio Diagnostics Holdings Inc. maintains a current ratio of 17.44, meaning it holds 17.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 4.18, indicating elevated leverage, while an interest coverage ratio of -531.72 demonstrates limited ability to service its debt obligations.

Current Ratio17.44
Quick Ratio15.81
Debt / Equity4.18
Debt / EBITDA-0.04
Interest Coverage-531.72

Financial Efficiency

USD

Over the twelve months ended September 30, 2026, Cardio Diagnostics Holdings Inc. posted a negative return on equity (ROE) of -93.55, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -87.24, reflecting losses generated across the asset base. The company generates approximately 1,012.33 in revenue per employee across its workforce of 15.00, a quick read on workforce productivity versus industry peers.

Return on Equity (ROE)-93.55
Return on Assets (ROA)-87.24
Revenue Per Employee1,012.33
Employee Count15.00

Stock Price Statistics

USD

As of the close on November 16, 2026, Cardio Diagnostics Holdings Inc.'s stock has declined approximately 47.51% over the past 52 weeks. The 50-day moving average sits at 1.84, while the 200-day moving average is 2.07.

52-Week Price Change-47.51%
50-Day Moving Average1.84
200-Day Moving Average2.07

Income Statement

USD

Over the twelve months ended September 30, 2026, Cardio Diagnostics Holdings Inc. generated 15,185.00 in revenue and converted that into -6.49M in net income, yielding earnings per share of -2.45. EBITDA reached -6.10M, while operating income came in at -6.48M.

Revenue15,185.00
Operating Income-6.48M
Pretax Income-6.49M
Net Income-6.49M
EBITDA-6.10M
EBIT-6.48M
Earnings Per Share (EPS)-2.45

Balance Sheet

USD

As of September 30, 2026, Cardio Diagnostics Holdings Inc. holds 3.94M in cash and equivalents against 238,883.00 in total debt, resulting in a net debt position of -3.94M. Total book value stands at 5.72M, with working capital of 4.10M providing operational flexibility.

Cash & Cash Equivalents3.94M
Total Debt238,883.00
Net Debt-3.94M
Equity (Book Value)5.72M
Book Value Per Share1.93
Working Capital4.10M

Cash Flow

USD

Cardio Diagnostics Holdings Inc. produced -5.78M in operating cash flow over the twelve months ended September 30, 2026. After subtracting -249,313.00 in capital expenditures, free cash flow totaled -6.03M - equivalent to -2.28 per share.

Operating Cash Flow-5.78M
Capital Expenditures-249,313.00
Free Cash Flow-6.03M
FCF Per Share-2.28

Margins

These figures cover the twelve months ended September 30, 2026. The operating margin of -42,649.75 and net profit margin of -42,721.93 provide insight into operational efficiency.

Operating Margin-42,649.75
Pretax Margin-42,721.93
Profit Margin-42,721.93
EBITDA Margin-40,142.71

Dividends & Yields

These figures cover the twelve months ended September 30, 2026. Free cash flow yield is negative at -119.96: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -64.37, meaning Cardio Diagnostics Holdings Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-64.37
FCF Yield-119.96

Stock Splits

Cardio Diagnostics Holdings Inc.'s most recent stock split took place on May 13, 2025 with a 30:1 split ratio.

Last Split Date5/13/2025
Split Ratio30:1

Scores

As of September 30, 2026, Cardio Diagnostics Holdings Inc. has an Altman Z-Score of -3.51, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-3.51